Mais recentes
-
População global de aves tropicais pode ter reduzido até 38% por conta do calor extremo
-
Sabe o que é achachairu? Não comeu nem ouviu falar? Conheça a fruta exótica que o Brasil já exporta
-
‘EUA pegaram pesado com o Brasil. Não vejo aonde querem chegar’, diz Arminio Fraga
-
'Nüshu': jovens chinesas resgatam antiga escrita secreta usada entre mulheres; conheça
Saúde
-
Celartics Biopharma's dendritic cell-based vaccine against COVID-19 infection found to efficiently produce viral antigen-specific T lymphocytes
Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
05-22
Detalhes -
Comprimidos da Yiling Pharmaceutical Lianhua Qingwen amplamente utilizados na China contra a epidemia
04-18
Detalhes -
Yiling Pharmaceutical Lianhua Qingwen Capsule helps prevent and control the global epidemic
04-10
Detalhes -
Li Yu, Administration of Traditional Chinese Medicine: Traditional Chinese Medicine Lianhua Qingwen Plays an Important Role in Fighting Against COVID-19
03-21
Detalhes